Cognition and Lewy body disease.
Laura Osona-Núñez1, Juan A Guisado-Macías, Marusa Pons
1Psychiatry Service, Hospital Infanta Cristina de Badajoz, Spain. lauraosona@gmail.com
Actas Espanolas De Psiquiatria
|July 20, 2011
Summary
This case study highlights Lewy body disease presenting with early cognitive and depressive symptoms, challenging initial diagnoses. Early identification and treatment with rivastigmine are crucial for managing this Parkinsonian disorder.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Parkinson disease (PD) clinical manifestations are evolving, with motor symptoms having improved treatments.
- Non-motor symptoms, particularly cognitive impairments, are increasingly recognized as primary disabilities in advanced PD.
- Cognitive decline in PD is prevalent and has devastating consequences for patients.
Observation:
- A 72-year-old woman presented with cognitive and depressive symptoms, initially suspected as a depressive disorder.
- Despite cognitive symptoms being more common in advanced stages, she was diagnosed with Lewy body disease.
Findings:
- The case demonstrates Lewy body disease with incipient cognitive, motor, and organic manifestations.
- Complementary tests supported the diagnosis of Lewy body disease.
Implications:
- This case underscores the psychiatric and neurological value of recognizing early cognitive symptoms in Lewy body disease.
- Rivastigmine is justified for treating Lewy body disease cases with predominant initial cognitive symptoms.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...